Accolade Inc

General ticker "ACCD" information:

  • Sector: Health Care
  • Industry: Health Care Providers & Services
  • Capitalization: $428.8M (TTM average)

Accolade Inc does not follow the US Stock Market performance with the rate: -14.5%.

Estimated limits based on current volatility of 0.1%: low 6.98$, high 7.00$

Factors to consider:

  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-02-29 to 2026-02-28

  • 2024-02-29 to 2025-02-28 estimated range: [8.38$, 14.89$]
  • 2025-02-28 to 2026-02-28 estimated range: [7.23$, 13.52$]

Financial Metrics affecting the ACCD estimates:

  • Negative: Non-GAAP EPS, $ of -1.33 <= 0.04
  • Negative: Operating cash flow per share per price, % of -1.73 <= 1.81
  • Negative: negative Operating income
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0 <= 0
  • Positive: -0.87 < Investing cash flow per share, $ of -0.85

Similar symbols

Short-term ACCD quotes

Long-term ACCD plot with estimates

Financial data

YTD 2022-02-28 2023-02-28 2024-02-29
Operating Revenue $310.02MM $363.14MM $414.29MM
Operating Expenses $435.75MM $826.66MM $528.75MM
Operating Income $-125.72MM $-463.51MM $-114.45MM
Non-Operating Income $-3.04MM $0.24MM $15.88MM
Income(Loss) $-128.76MM $-463.27MM $-98.57MM
Taxes $-5.64MM $-3.62MM $1.24MM
Profit(Loss)* $-123.12MM $-459.65MM $-99.81MM
Stockholders Equity $855.79MM $473.79MM $445.46MM
Inventory $3.02MM $4.02MM $0.00MM
Assets $1,285.53MM $903.07MM $788.15MM
Operating Cash Flow $-62.35MM $-40.70MM $-16.17MM
Capital expenditure $3.62MM $7.23MM $12.48MM
Investing Cash Flow $-263.61MM $-7.23MM $-63.63MM
Financing Cash Flow $257.93MM $3.16MM $-55.57MM
Earnings Per Share** $-1.93 $-6.45 $-1.33

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.